Patrick Roy

From indomethacin to a selective COX-2 inhibitor: Development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors

W. Cameron Black, Christopher I. Bayly, Michel Belley et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 108 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Temporally distinct accumulation of transcripts encoding enzymes of the prechorismate pathway in elicitor-treated, cultured tomato cells.

J Görlach, Hanns -R. Raesecke, Doris Rentsch et al. · Proceedings of the National Academy of Sciences · 1995 · 99 citations · Full text

Life Sciences, Biochemistry, Plant Biology +17

The Interaction of Arginine 106 of Human Prostaglandin G/H Synthase-2 with Inhibitors Is Not a Universal Component of Inhibition Mediated by Nonsteroidal Anti-inflammatory Drugs

Gillian Greig, Donna A. Francis, Jean‐Pierre Falgueyret et al. · Molecular Pharmacology · 1997 · 87 citations

Medicine, Medicinal Chemistry, Pharmacology +13

Nicotinic Acetylcholine Receptors Modulate Bone Marrow-Derived Pro-Inflammatory Monocyte Production and Survival

Stéphanie St‐Pierre, Wei Jiang, Patrick Roy et al. · PLoS ONE · 2016 · 71 citations · Full text

Life Sciences, Immunology, Pharmacology +17

The development of potent non-peptidic PTP-1B inhibitors

Claude Dufresne, Patrick Roy, Zhaoyin Wang et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 69 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +9